Abstract:In the past, little attention had been paid to the intestine and its microbial flora as a potential source of systemic inflammation in chronic kidney disease(CKD). Systemic inflammation plays a central role in progression of CKD and its cardiovascular and various other complications. The gastrointestinal tract houses a large community of microbes that have a symbiotic relationship with the host. The normal microbial flora protects the host against pathogenic microorganisms. It also contributes to the energy metabolism, micronutrient homeostasis and nitrogen bal- ance. Recent studies have revealed significant changes in the composition and function of the microbial flora in CKD patients and animals. These changes are driven by altered intestinal bio- chemical environment caused by: I-heavy influx of urea and uric acid from body fluids into the gastrointestinal tract, II- restrictions of potassium-rich food including fruits and vegetables which as the main source of indigestible complex carbohydrates are the essential nutrients for the guts' symbiotic microbial com- munity, and III- various medications such as phosphate binders, antibiotics etc. Together the changes in intestinal milieu and the resultant microbial dysbiosis play a major role in systemic inflammation and uremic toxicity by several mechanisms : I-generation of several microbial derived uremic toxins such as indoxyl sulfate, p-cresol sulfate and trimethylamine-N-oxide etc. II-reduction of microbial derived micronutrients such a short chain fatty acids (SCFA) which are the main source of nutrients for colonocytes. This is caused by diminished substrates (indigestible complex carbohydrates) which leads to depletion of SCFA-making bacteria. In addition, III-Disruption of the intestinal epithelial barrier by ammonia and ammonium hydroxide generated from hydrolysis of urea by urease-possessing microbial species which are common complications of CKD, and bowel ischemia caused by excessive use of diuretics (in CKD patients) and aggressive ultrafiltration by hemodialysis (in ESRD patients) can impair gastrointestinal epithelial barrier. The resulting breakdown of the gut epithelial barrier (tight junction complex) leads to influx of endotoxin, microbial fragments, and other noxious luminal products in the sub-epithelial tissue and systemic circulation leading to local and systemic inflammation and oxidative stress which are the major cause of morbidity and mortality in CKD population. This review is intended to provide an overview of the effects of CKD on the gut microbiome and intestinal epithelial barrier structure and the potential interventions aimed at mitigating these abnormalities.

Is the enteric nervous system a lost piece of the gut-kidney axis puzzle linked to chronic kidney disease?

The enteric nervous system in gastrointestinal disease etiology

Enteric Nervous System and Its Relationship with Neurological Diseases

Enteric Nervous System Alterations in Inflammatory Bowel Disease: Perspectives and Implications

Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication

Homeostasis in the Gut Microbiota in Chronic Kidney Disease

Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease

Link between gut microbiota dysbiosis and chronic kidney disease.

Altered Expression of Intestinal Tight Junctions in Patients with Chronic Kidney Disease: A Pathogenetic Mechanism of Intestinal Hyperpermeability

Advances in Enteric Neurobiology: The "Brain" in the Gut in Health and Disease

Mechanisms of enteric neuropathy in diverse contexts of gastrointestinal dysfunction

[Uremic toxins and gut micro biome]

Gut microbiota associations with chronic kidney disease: insights into nutritional and inflammatory parameters

Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate

Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease

Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins

The gut microbiota and its relationship with chronic kidney disease

Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components

High-fat diets on the enteric nervous system: Possible interactions and mechanisms underlying dysmotility

Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders

Immunosenescence, Gut Dysbiosis, and Chronic Kidney Disease: Interplay and Implications for Clinical Management